Inactive Instrument
Checkmate Pharmaceuticals, Inc. Share Price
Stocks
CMPI
US1628181083
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 11/12/2018 | |
Robert Landry
DFI | Director of Finance/CFO | 62 | 30/05/2022 |
James Wooldridge
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 30/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/22 | Issuer sale | Director | 36,778 | 0.1700% | ||
| 31/05/22 | Issuer sale | Chief Financial Officer | 278,480 | 1.2874% | ||
| 31/05/22 | Issuer sale | Chief Executive Officer | 279,437 | 1.2919% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.38% | - | - | 231M | |
| -3.30% | +1.50% | +51.24% | +99.26% | 72.26B | |
| +1.25% | -3.01% | +40.12% | +77.12% | 60.24B | |
| +2.12% | +5.26% | +32.50% | +21.28% | 27.73B | |
| -3.06% | -1.81% | -13.10% | +357.06% | 25.74B | |
| -0.75% | +2.56% | +0.45% | -4.46% | 24.75B | |
| +0.40% | +0.75% | +22.91% | -9.68% | 20.74B | |
| -1.70% | -2.12% | +146.86% | +314.52% | 15.06B | |
| +0.36% | -0.34% | +50.32% | +166.42% | 14.42B | |
| +0.21% | +1.17% | -8.07% | +499.10% | 14.23B | |
| Average | -0.45% | +0.44% | +35.92% | +168.96% | 30.57B | |
| Weighted average by Cap. | -0.77% | +0.31% | +36.31% | +129.11% |
Employees
31
